abeluchin Posted August 2, 2023 Share Posted August 2, 2023 Hi group; our OB colleagues use Methergine (ergonovine) for treatment or prophylaxis of postpartum hemorrhage. The medication label from the manufacturer recommends to hold breast feeding up to 12 hours after last dose due to unpublished reported side effects in the babies i did a literature search and found only one article published in Pubmed that covers that topic: https://pubmed.ncbi.nlm.nih.gov/27846760/ min this prospective study they found no side effects in breastfed babies Are there any other reference on this topic that you can share? is this something that affects your newborn nursery practice in your hospital? Thanks for any input Link to comment Share on other sites More sharing options...
Stefan Johansson Posted August 4, 2023 Share Posted August 4, 2023 I found this more extensive writeup about methergine in LactMed, but otherwise nothing more substantial info Interesting how unpublished case reports (to the manufacturer) can have such impact. https://www.ncbi.nlm.nih.gov/books/NBK501342/ Link to comment Share on other sites More sharing options...
abeluchin Posted August 4, 2023 Author Share Posted August 4, 2023 Hi Johan; thanks for your insight. That’s the reality of my hospital. The anti lactation has taken this unpublished recommendation to prevent mother to lactate their infants Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now